Deniz Şahin

Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

Giuseppe Boriani, Marco Proietti, Cécile Laroche et al. · EP Europace · 2017 · 166 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20⁺ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

Laurie H. Sehn, André Goy, Fritz Offner et al. · Journal of Clinical Oncology · 2015 · 154 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA

Laurie H. Sehn, Maurizio Martelli, Marek Trněný et al. · Journal of Hematology & Oncology · 2020 · 143 citations · Full text

Medicine, Hematology, Oncology +17

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

Giuseppe Boriani, Marco Proietti, Cécile Laroche et al. · EP Europace · 2019 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17